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Abstract
Background: Very old critical ill patients are a rapid expanding group. To better understand the magnitude of the
challenges involved in intensive care practice for an ageing population and discuss a rational allocation of
resources, healthcare practitioners need a reliable evaluation of frailty. In order to promote the adequate use of the
Clinical Frailty Scale (CFS) in a wider panel of countries, we aimed to develop, validate and characterise a French
(FR) version from the original English (EN) CFS.
Methods: We included participants recruited prospectively for the observational “The very old intensive care
patient: A multinational prospective observation study” (VIP Study) at Geneva University Hospitals (FR speaking
hospital). A FR version of the CFS was obtained by translation (EN- > FR) and back translation (FR- > EN). The final
CFS-FR was then evaluated twice on the same participants with at least a 2-week interval by FR-speaking doctors
and nurses.
Results: Inter-rater reliability was 0.87 (95%CI: 0.76–0.93) between doctors for the original CFS version and 0.76
(95%CI: 0.57–0.87) between nurses for the FR version. Inter-rater variability between doctor and nurse was 0.75
(95%CI: 0.56–0.87) for the original version, and 0.73 (95%CI: 0.52–0.85) for the FR version.
Test-retest (stability) with the original vs the FR version was 0.86 (95%CI: 0.72–0.93) for doctors and 0.87 (95%CI:
0.76–0.93) for nurses.
Differences between the evaluations of the CFS-EN and CSF-FR were not different from 0, with a mean difference
of 0.06 (95%CI -0.24, 0.36) for the EN version and − 0.03 (95%CI -0.47, 0.41) for the FR version. Average original
version ratings were slightly lower than FR version ratings, though this difference did not reach significance: -0.29
(95%CI -0.54, 0.04).
Conclusion: In this prospective cohort of very old intensive care participants we developed and tested the basic
psychometric properties (internal consistency, reproducibility) of a French version of the CFS. This manuscript
provides clinically meaningful psychometric properties that have not been previously reported in any other
language, including in the original EN version.
The French cultural adaptation of this CFS has adequate psychometric properties for doctors or nurses to evaluate
frailty in very old intensive care patients.
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Introduction
As Europeans continue to experience increasing life-
spans, surgical and perioperative care for the old (> 65)
and very old (> 80 years) patients has become common-
place, and is expected to continue to increase in volume
and complexity in future decades. Advanced age, as a
risk factor in surgery, is the complex combination of an
increased probability of comorbidities and “frailty”.
Frailty is an insufficiently understood decline in physio-
logical reserve and resilience that may be related to en-
ergy production, energy utilization and defective repair
mechanisms [1]. Frailty is strongly associated with in-
creased mortality after intensive care (ICU) admission,
even when controlling for chronological age and other
risk factors [2].
To better understand the magnitude of the challenges
involved in intensive care practice for an ageing popula-
tion and discuss a rational allocation of resources,
healthcare practitioners need a reliable evaluation of
frailty [3]. There are multiple instruments to evaluate
frailty with a diverse range of complexity, from the 70
items Frailty Index (FI) [4] to the more feasible clinical
frailty scale (CFS) [5]. The latter, an ordinal 9-point vis-
ual scale in which the assessor makes decisions about
the degree of frailty from clinical data, is well correlated
with the FI (r = 0.80), but much easier to conduct [5].
The score ranges from very fit (CFS = 1) to very severely
frail (CFS = 8) and terminally ill (CFS = 9) (Fig. 1). Frailty
is usually defined as CFS > 4 [6].
Frailty assessment using tools such as the CFS should
be part of the standard multimodal evaluation routinely
performed in older adults [5]. However, after a literature
search we were only able to identify the original English
(EN) version of the CFS validation, thereby limiting its
use by clinicians from other native languages. The use of
the EN version or a non-validated translation of the CFS
by healthcare personnel can result in different assess-
ments and contribute to biases. Items could be answered
differently because of differences in translation or cul-
ture instead of differences in actual patients’ status,
which can lead to inadequate scoring of frailty. There-
fore, in order to promote the adequate use of this scale
Fig. 1 Clinical Frailty Scale, Original EN Version (CFS-EN-original). Permission to use the CSF was granted from Dalhousie University, Ca. May 15. 2017
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in a wider panel of countries, we aimed to develop, val-
idate and characterise a French (FR) version of the CFS.
Methods
We included participants recruited prospectively for the
observational “The very old intensive care patient: A
multinational prospective observation study” (VIP Study)
[3] in the Intensive Care and Peri-Interventional Inter-
mediate Care Units at Geneva University Hospitals (FR
speaking hospital), between January and July 2017. The
study was approved by the Geneva Regional Ethics Com-
mittee (Commission cantonale d’éthique de la recherche
de Genève, CCER: 2016–01773, President: Professor
Bernard Hirschel) that waived the need for informed
consent. Observational data were collected according to
international ethics standards conforming to the Declar-
ation of Helsinki [7].
Obtaining a French version for testing
The translation from EN to FR was made in 4 steps by 4
clinicians (2 doctors and 2 nurses) with C2 (Europass)
level of both languages, whose native language is FR.
The text was then back-translated into EN by 2 inde-
pendent clinicians (doctor and nurse) with the same lan-
guage skills whose native language was EN. They were
blinded to the original EN version. All translators were
aware of the study design.
The original EN (CFS-EN) and EN back-translated
versions were then compared qualitatively. Differences
or incoherence between the two versions (CFS-EN ori-
ginal and EN-back-translated) were resolved by agree-
ment in order to improve the French translated version.
The FR version was then further assessed by 5 Health-
care workers whose native language is French (nurses
and doctors) working in the Geneva intensive or inter-
mediate care units. Their feedback was used to further
modify the scale and obtain the definite FR translated
version (CFS-FR).
Characterizing and validating the FR-final version
The CFS was evaluated twice on the same participants
with at least a 2-week interval. Evaluators were either of
the same profession (nurse or physician) or of differing
profession, to assess interjudge agreement within and
between professions. The CFS was also assessed twice by
the same evaluators, to evaluate test-retest reliability.
Furthermore, the scale used was either in the same lan-
guage or of differing language, to assess whether the rat-
ings were similar with the French, compared to the
English version of the scale. Doctors evaluated the
Fig. 2 Clinical Frailty Scale, French translated final version (CFS-FR). Permission to use the CSF was granted from Dalhousie University, Ca. May 15. 2017
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English version twice and nurses evaluated the French
version twice. Evaluators were blinded to each other’s
evaluation.
Criterion validity was assessed by examining the
relation of CFS-EN and CFS-FR with mortality at
30-days after ICU admission, using Wilcoxon rank
sum test.
Interjudge reliability and test-retest reliability were
assessed using intraclass correlation (ICC) and Bland
and Altman plot. ICC inter-rater agreement measures
were considered poor - Less than 0.40, fair - Between
0.40 and 0.59, good - Between 0.60 and 0.74, excellent -
Between 0.75 and 1.00 [8].
Results
Of the 40 participants recruited to the VIP1 study, the
CFS evaluation was performed in 34 participants. In 6
(15%) participants, one or more operators were not able
to provide a score due to insufficient data on participant
health status prior to ICU admission. These 6 partici-
pants were excluded from further analysis. Mortality fol-
low up was completed for all participants. Participants
were mostly female (57%) and were on average 84.1
years old.
Inter-rater reliability was 0.87 (95%CI: 0.76–0.93) be-
tween doctors for the EN version (Fig. 1), and 0.76
(95%CI: 0.57-0.87) between nurses for the FR version
Fig. 3 Bland et Altman plot for CFS scoring between 2 independent Doctors with CFS-EN (a), between 2 independent Nurses with CFS-FR (b),
with the EN then FR version by Doctor (c)
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(Fig. 2). Inter-rater variability between doctor and nurse
was 0.75 (95%CI: 0.56-0.87) for the EN version, and 0.73
(95%CI: 0.52-0.85) for the FR version.
Test-retest (stability) with the EN vs the FR version
was 0.86 (95%CI: 0.72–0.93) for doctors and 0.87
(95%CI: 0.76–0.93) for nurses.
Differences between the evaluations of the CFS-EN and
CSF-FR were not different from 0, with a mean difference of
0.06 (95%CI -0.24-0.36) for the EN version and -0.03
(95%CI -0.47-0.41) for the FR version (Fig. 3a, b). Agreement
between the FR and the EN version for doctors was similar
(Fig. 3c). Average English version ratings were slightly lower
than French version ratings, though this difference did not
reach significance: -0.29 (95%CI -0.54-0.04).
There were 15 deaths within 30-days of ICU admis-
sion. There were no significant differences in the CFS
scores between participants who died within 30 days and
participants who survived for either the EN (median sur-
vived: 4.7, median died: 4.0, p = 0.52) or FR (median sur-
vived: 4.7, median died: 4.5, p = 0.56) versions.
Discussion
Overall, the EN and FR versions of the CFS exhibited
good to excellent interjudge reliability, between doctors,
between nurses, and to a lesser extent between nurses
and doctors [8]. The test retest of either the FR or the
EN versions showed a good stability. Bland and Altman
representation showed a good agreement between doc-
tors (see Fig. 3a).
Only 2 measures differed by more than 2 points with
the CFS-EN scale performed by 2 independent doctors.
Agreement between nurses with the FR version was fair
(see Fig. 3b). Moreover, agreement between the FR and
the EN versions for Doctors seemed strong enough to
validate this EN-to-FR translation in clinical practice
(see Fig. 3c).
As expected, the CFS scores were slightly higher in
participants who died than in those who survived,
though significance could not be achieved in this small
cohort.
This study has some limitations. This is a report of a
simple study using a standard forward-back translation
method to develop and test a French version of an Eng-
lish questionnaire. The characterization and validation
the FR-final version was performed in a relatively small
number of participants, as this was a convenience sam-
ple using patients enrolled in the larger VIP1 study in
Geneva University Hospitals. However, our sample size
of 40 patients would allow us to detect an ICC of 0.75
with a half-confidence interval width of 0.25. In 6 pa-
tients one or more operators were not able to provide a
score due to insufficient data, thus raising the possibility
of selection bias. Importantly, all values from the CFS
except 9 are represented in the sample; hence in our
opinion it is unlikely that the missing patients have an
important influence in the validation study considering
the range of analyses performed.
Conclusion
In this prospective cohort of very old intensive care par-
ticipants we developed and tested the basic psychometric
properties (internal consistency, reproducibility) of a
French version of the CFS. This manuscript provides
clinically meaningful psychometric properties that have
not been previously reported in any other language, in-
cluding in the original EN version [5]. The French cul-
tural adaptation of this CFS has adequate psychometric
properties for doctors or nurses to evaluate frailty in
very old intensive care patients.
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